Five Prime Therapeutics, Inc. Contract with Customer, Asset, after Allowance for Credit Loss
Five Prime Therapeutics, Inc. had Contract with Customer, Asset, after Allowance for Credit Loss of $85.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Balance Sheet › Assets
us-gaap:ContractWithCustomerAssetNet · last filed 2021-03-22
- 2020-12-31: Contract with Customer, Asset, after Allowance for Credit Loss $85.00K.
- 2020-09-30: Contract with Customer, Asset, after Allowance for Credit Loss $1.48M.
- 2020-06-30: Contract with Customer, Asset, after Allowance for Credit Loss $2.21M.
- 2020-03-31: Contract with Customer, Asset, after Allowance for Credit Loss $2.17M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss |
|---|---|
| 2020-12-31 | $85.00K 10-K · filed 2021-03-22 |
| 2020-09-30 | $1.48M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $2.21M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.17M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $4.10M 10-K · filed 2021-03-22 |
| 2019-09-30 | $3.66M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.60M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $3.36M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.10M 10-K · filed 2020-02-27 |
| 2018-09-30 | $5.01M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.71M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $4.27M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $13.13M 10-K · filed 2019-02-26 |